Medtronic plc (MDT)
Medtronic (MDT) Exceeds Market Returns: Some Facts to Consider
Medtronic (MDT) reached $83.87 at the closing of the latest trading day, reflecting a +1.8% change compared to its last close.
Medtronic: Undervalued, And The Tailwinds Are Just Getting Started
I initiate coverage on Medtronic, highlighting its status as a leading medtech name with premium margins. MDT offers an attractive diversification opportunity, combining consistent performance with accelerated revenue growth. The stock trades at undervalued levels, supporting a long-term bullish thesis and a defensive investment approach.
Medtronic: A Near Decade High Dividend For This Aristocrat
Medtronic is a dividend aristocrat with a near-decade high yield, making it an attractive long-term income opportunity. The company is experiencing strong revenue growth, driven by its leading positions in cardiovascular and neuroscience medical devices. While current free cash flow payout ratios are sustainable, investors should monitor future dividend growth rates closely.
Why Is Medtronic (MDT) Up 1.5% Since Last Earnings Report?
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock?
Medtronic (MDT) Stock Sinks As Market Gains: What You Should Know
Medtronic (MDT) reached $78.23 at the closing of the latest trading day, reflecting a -3.34% change compared to its last close.
Is It Worth Investing in Medtronic (MDT) Based on Wall Street's Bullish Views?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
This Undervalued Medical-Devices Stock Is Poised for a Rebound
Medtronic offers high growth potential in addition to discounted valuation.
Is the Options Market Predicting a Spike in Medtronic Stock?
Investors need to pay close attention to MDT stock based on the movements in the options market lately.
Got $2,500? 1 Unstoppable Medical Juggernaut to Buy Hand Over Fist and Hold for the Next 20 Years
For an investor in their 50s or 60s who is finished chasing trends, Medtronic (NYSE:MDT | MDT Price Prediction) is a stock worth owning for decades because it pairs inelastic demand for medical devices with a 49th consecutive year of dividend increases.
Dividend Announcements: May 30-June 5, 2026
In this article series, I summarize dividend announcements of the past week. Six stocks in my database announced dividend increases, including one stock I own, and one declared a special dividend. W. R. Berkley stands out with an 11.1% dividend increase, a 50¢ special dividend, and the highest quality score this week. Medtronic offers the most value, trading 9% below fair value, but its dividend growth is modest at 1.4%.
Medtronic Bets on Ablation, Robotics, and Hypertension
MDT is betting on ablation, robotics and hypertension therapies as next growth drivers, but tariffs, FX and pricing pressures cloud near-term upside.
Is Medtronic Stock a Buy at 14x Forward Earnings?
MDT trades at about 14x forward earnings with a 3.5% yield as fiscal 2027 guidance points to steady growth, but margins face tariffs and mix pressure.
